InMed Pharmaceuticals Inc. (FRA:MWG)
1.050
+0.080 (8.25%)
At close: Dec 19, 2025
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of €4.02 million as of December 22, 2025. Its market cap has increased by 30.68% in one year.
Market Cap
4.02M
Enterprise Value
-3.44M
Revenue
4.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.05
Market Cap Chart
Since May 6, 2014, InMed Pharmaceuticals's market cap has decreased from 6.75M to 4.02M, a decrease of -40.48%. That is a compound annual growth rate of -4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.02M | 21.13% |
| Dec 31, 2024 | 3.32M | 67.64% |
| Dec 29, 2023 | 1.98M | -34.19% |
| Dec 30, 2022 | 3.01M | -81.55% |
| Dec 31, 2021 | 16.28M | -13.51% |
| Dec 31, 2020 | 18.83M | -31.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |